As of 2025-10-21, the Relative Valuation of Abivax SA (ABVX.PA) is (19.36) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 79.60 EUR, the upside of Abivax SA based on Relative Valuation is -124.3%.
The range of the Relative Valuation is (18.45) - (21.90) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 7.2x | 5.9x |
| Forward P/E multiples | 6.1x - 7.6x | 6.8x |
| Fair Price | (18.45) - (21.90) | (19.36) |
| Upside | -123.2% - -127.5% | -124.3% |
| Date | P/E |
| 2025-10-20 | -26.05 |
| 2025-10-17 | -25.95 |
| 2025-10-16 | -26.81 |
| 2025-10-15 | -27.37 |
| 2025-10-14 | -27.63 |
| 2025-10-13 | -27.14 |
| 2025-10-10 | -26.15 |
| 2025-10-09 | -26.11 |
| 2025-10-08 | -25.22 |
| 2025-10-07 | -24.43 |
| 2025-10-06 | -25.19 |
| 2025-10-03 | -23.87 |
| 2025-10-02 | -23.14 |
| 2025-10-01 | -23.50 |
| 2025-09-30 | -23.77 |
| 2025-09-29 | -23.44 |
| 2025-09-26 | -23.24 |
| 2025-09-25 | -23.17 |
| 2025-09-24 | -23.64 |
| 2025-09-23 | -23.24 |
| 2025-09-22 | -22.94 |
| 2025-09-19 | -23.21 |
| 2025-09-18 | -23.11 |
| 2025-09-17 | -22.94 |
| 2025-09-16 | -22.68 |
| 2025-09-15 | -23.70 |
| 2025-09-12 | -23.37 |
| 2025-09-11 | -23.70 |
| 2025-09-10 | -24.40 |
| 2025-09-09 | -25.25 |
| 2025-09-08 | -24.89 |
| 2025-09-05 | -25.29 |
| 2025-09-04 | -24.06 |
| 2025-09-03 | -23.64 |
| 2025-09-02 | -22.81 |
| 2025-09-01 | -22.28 |
| 2025-08-29 | -22.71 |
| 2025-08-28 | -22.71 |
| 2025-08-27 | -22.74 |
| 2025-08-26 | -22.35 |
| 2025-08-25 | -21.62 |
| 2025-08-22 | -21.98 |
| 2025-08-21 | -20.63 |
| 2025-08-20 | -19.50 |
| 2025-08-19 | -19.44 |
| 2025-08-18 | -19.73 |
| 2025-08-15 | -19.83 |
| 2025-08-14 | -19.50 |
| 2025-08-13 | -19.73 |
| 2025-08-12 | -19.73 |